09:51 AM EST - Knight Therapeutics Inc. : today reported financial results for the year ended December 31, 2014. The Company reported revenues of $365,323 and net income of $125,858,872. As at December 31, 2014, the Company had $416.8 million in cash and marketable securities and 90,818,595 common shares outstanding. Knight Therapeutics Inc.
shares T.GUD are trading down $0.23 at $8.83.
